Biogen Inc. buy Needham & Company LLC
Start price
01.08.24
/
50%
€198.10
Target price
01.08.25
€266.57
Performance (%)
-42.66%
End price
02.08.25
€113.60
Summary
This prediction ended on 02.08.25 with a price of €113.60. Massive losses of -42.66% were the result for the BUY prediction by Needham___Company_LL. Needham___Company_LL has a follow-up prediction for Biogen Inc. where he still thinks Biogen Inc. is a Buy. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Biogen Inc. | 3.151% | 3.151% | 67.323% |
| iShares Core DAX® | -1.111% | -0.848% | 2.018% |
| iShares Nasdaq 100 | -4.346% | -5.765% | 26.249% |
| iShares Nikkei 225® | -6.785% | -10.345% | 53.208% |
| iShares S&P 500 | -1.788% | -0.332% | 21.463% |
Comments by Needham___Company_LL for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $288.00 price target on the stock.
Ratings data for BIIB provided by MarketBeat
In the thread Trading Biogen Inc.
Die von Needham___Company_LL gewählte maximale Laufzeit wurde überschritten